Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lübbert

Showing results (51-60 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|January 3, 2014
Clinical development of demethylating agents in hematologyShyamala C Navada, Juliane Steinmann, Michael Lübbert, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Myelodysplastic syndromesWolf-Karsten Hofmann, Michael Lübbert, Dieter Hoelzer, et al.
Cancer Research|August 17, 2005
Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndromeCora Mund, Björn Hackanson, Carlo Stresemann, et al.
Leukemia Research|October 24, 2006
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell linesTobias Berg, Yalin Guo, Mahmoud Abdelkarim, et al.
Blood|July 24, 2007
Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7Björn Rüter, Pierre Wijermans, Rainer Claus, et al.
Epigenetics|August 1, 2017
Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemiaJens Przybilla, Lydia Hopp, Michael Lübbert, et al.
Leukemia Research|May 6, 2008
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancerHenning Sebastian Schäfer, Heiko Becker, Annette Schmitt-Gräff, et al.
Journal of Hematotherapy & Stem Cell Research|March 29, 2003
Side-population cells from different precursor compartmentsYalin Guo, Marie Follo, Klaus Geiger, et al.
Pharmaceutical Statistics|May 18, 2021
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing eventsRegina Stegherr, Claudia Schmoor, Michael Lübbert, et al.
Scientific Reports|December 23, 2022
Absence of early platelet increment in healthy mice during decitabine treatmentJuliane Baumann, Markus Spindler, Yannick Throm, et al.
Pageof 25

Showing results (51-60 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|January 3, 2014
Clinical development of demethylating agents in hematologyShyamala C Navada, Juliane Steinmann, Michael Lübbert, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Myelodysplastic syndromesWolf-Karsten Hofmann, Michael Lübbert, Dieter Hoelzer, et al.
Cancer Research|August 17, 2005
Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndromeCora Mund, Björn Hackanson, Carlo Stresemann, et al.
Leukemia Research|October 24, 2006
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell linesTobias Berg, Yalin Guo, Mahmoud Abdelkarim, et al.
Blood|July 24, 2007
Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7Björn Rüter, Pierre Wijermans, Rainer Claus, et al.
Epigenetics|August 1, 2017
Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemiaJens Przybilla, Lydia Hopp, Michael Lübbert, et al.
Leukemia Research|May 6, 2008
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancerHenning Sebastian Schäfer, Heiko Becker, Annette Schmitt-Gräff, et al.
Journal of Hematotherapy & Stem Cell Research|March 29, 2003
Side-population cells from different precursor compartmentsYalin Guo, Marie Follo, Klaus Geiger, et al.
Pharmaceutical Statistics|May 18, 2021
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing eventsRegina Stegherr, Claudia Schmoor, Michael Lübbert, et al.
Scientific Reports|December 23, 2022
Absence of early platelet increment in healthy mice during decitabine treatmentJuliane Baumann, Markus Spindler, Yannick Throm, et al.
Pageof 25